Data Insights
By Company Name
No filters selected
By Disease Name
No filters selected
By Drug Name
No filters selected
By Themes
No filters selected
Showing 1 results out of 1
Data Insights
Dofetilide by Hyloris Pharmaceuticals for Atrial Flutter: Likelihood of Approval
Dofetilide is under clinical development by Hyloris Pharmaceuticals and currently in Phase I for Atrial Flutter. According to GlobalData, Phase...